Biliary tract cancer

You have access
Efficacy and Feasibility of Adjuvant Gemcitabine Plus Cisplatin Chemotherapy After Major Hepatectomy for Biliary Tract Cancer
SHOZO MORI, TAKU AOKI, TAKAYUKI SHIRAKI, TAKAYUKI SHIMIZU, TAKAMUNE YAMAGUCHI, KYUNG-HWA PARK, TAKATSUGU MATSUMOTO, YUHKI SAKURAOKA, YUKIHIRO ISO and KEIICHI KUBOTA

Anticancer Research October 2021, 41 (10) 5231-5240; DOI: https://doi.org/10.21873/anticanres.15342
You have access
Comparison of Inflammation-based Prognostic Scores in Patients With Biliary Tract Cancer After Surgical Resection
MASASHI UTSUMI, KOJI KITADA, NAOYUKI TOKUNAGA, YUSUKE YOSHIDA, TORU NARUSAKA, RYOSUKE HAMANO, HIDEAKI MIYASOU, YOUSUKE TSUNEMITSU, SHINYA OTSUKA and MASARU INAGAKI

Anticancer Research April 2021, 41 (4) 2147-2155; DOI: https://doi.org/10.21873/anticanres.14987
You have access
Clinical Trial of a Cancer Vaccine Targeting VEGF and KIF20A in Advanced Biliary Tract Cancer
MUTSUNORI MURAHASHI, TOSHIHISA TSURUTA, KAZUNARI YAMADA, YASUKI HIJIKATA, HISANOBU OGATA, JUNJI KISHIMOTO, SACHIKO YOSHIMURA, TETSURO HIKICHI, YOICHI NAKANISHI and KENZABURO TANI

Anticancer Research March 2021, 41 (3) 1485-1496; DOI: https://doi.org/10.21873/anticanres.14907
You have access
Second-line Treatment in Advanced Biliary Tract Cancer: Today and Tomorrow
ALESSANDRO RIZZO, ANGELA DALIA RICCI, NASTASSJA TOBER, MARIA CONCETTA NIGRO, MIRTA MOSCA, ANDREA PALLONI, FRANCESCA ABBATI, GIORGIO FREGA, STEFANIA DE LORENZO, SIMONA TAVOLARI and GIOVANNI BRANDI

Anticancer Research June 2020, 40 (6) 3013-3030; DOI: https://doi.org/10.21873/anticanres.14282
You have access
Preoperative Neutrophil-to-lymphocyte Ratio Predicts Tumor-infiltrating CD8⁺ T Cells in Biliary Tract Cancer
RYOTA TANAKA, KENJIRO KIMURA, SHINPEI EGUCHI, JUN TAUCHI, MASATUNE SHIBUTANI, HIROJI SHINKAWA, GO OHIRA, SADAAKI YAMAZOE, SHOGO TANAKA, RYOSUKE AMANO, HIROAKI TANAKA, MASAKAZU YASHIRO, SHOJI KUBO and MASAICHI OHIRA

Anticancer Research May 2020, 40 (5) 2881-2887; DOI: https://doi.org/10.21873/anticanres.14264
You have access
Aberrant Methylation of Tumor Suppressive miRNAs in Bile from Patients With Pancreaticobiliary Diseases
KOUSHIRO OHTSUBO, KUNIO MIYAKE, SACHIKO ARAI, KOJI FUKUDA, NAOHIRO YANAGIMURA, CHIAKI SUZUKI, SAKIKO OTANI, YUTA ADACHI, AZUSA TANIMOTO, AKIHIRO NISHIYAMA, KANAME YAMASHITA, SHINJI TAKEUCHI, KENJI NOTOHARA, KENICHI YOSHIMURA and SEIJI YANO

Anticancer Research October 2019, 39 (10) 5449-5459; DOI: https://doi.org/10.21873/anticanres.13738
You have access
The Modified Glasgow Prognostic Score in Patients with Gemcitabine-refractory Biliary Tract Cancer
NAOHIRO OKANO, AKIYOSHI KASUGA, KIRIO KAWAI, YOSHIYA YAMAUCHI, TAKAAKI KOBAYASHI, DAISUKE NARUGE, FUMIO NAGASHIMA and JUNJI FURUSE

Anticancer Research March 2018, 38 (3) 1755-1761;
You have access
Axitinib for Gemcitabine-refractory Advanced Biliary Tract Cancer: Report of 5 Cases
NAOHIRO OKANO, AKIYOSHI KASUGA, KIRIO KAWAI, TAKAAKI KOBAYASHI, DAISUKE NARUGE, FUMIO NAGASHIMA and JUNJI FURUSE

Anticancer Research July 2017, 37 (7) 3711-3715;
You have access
Surgical Resection for Pulmonary Metastasis from Pancreatic and Biliary Tract Cancer
TETSUZO TAGAWA, KENSAKU ITO, KENGO FUKUZAWA, TATSURO OKAMOTO, ATSURO YOSHIMURA, TAKAHIDE KAWASAKI, TAKASHI MASUDA, KENTARO IWAKI, TAKAHIRO TERASHI, MASAHIRO OKAMOTO, AKIO SHIROMIZU, AKIRA MOTOHIRO and YOSHIHIKO MAEHARA

Anticancer Research March 2017, 37 (3) 1413-1416;
You have access
Multicenter Phase II Clinical Trial of Genexol-PM® with Gemcitabine in Advanced Biliary Tract Cancer
JIN YOUNG KIM, YOUNG ROK DO, HONG SUK SONG, YOON YOUNG CHO, HUN MO RYOO, SUNG HWA BAE, JONG GWANG KIM, YEE SOO CHAE, BYUNG WOOG KANG, JIN HO BAEK, MIN KYOUNG KIM, KYUNG HEE LEE and KEONUK PARK

Anticancer Research March 2017, 37 (3) 1467-1473;

Main menu

User menu

Search

Biliary tract cancer

Pages